Notably, the mutation rate of NFKBIZ was higher in intestinal epithelial cells in the context of ulcerative colitis, but lower in colitis-led tumor cells, suggesting that intestinal epithelial cells may resist tumor transformation through selective NFKBIZ mutation [9]. The gene discussed is NFKBIZ; the disease is neoplasm.